American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)
Objective: The purpose of this study is to compare the incidences of bleeding and thrombosis, and the transfusion requirements in patients randomized to receive TXA or a placebo for hypoproliferative thrombocytopenia secondary to primary marrow disorders, chemotherapy, immunotherapy, radiation and/or hematopoietic stem cell transplant. ClinicalTrials.gov NCT02578901.
- University of Washington
- Medical Center - Clinical Coordinating Center
- Department of Biostatistics - Data Coordinating Center
- University of Pittsburgh
- University of North Carolina at Chapel Hill